###### Article summary

Article focus
=============

-   Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke-protocol for a neurophysiological study.

Key messages
============

-   Reliable and valid tools must be used to assess spasticity accurately in clinical and research settings.

-   The results of this protocol will provide evidence for the validity of the MMAS and the MTS for the measurement of muscle spasticity.

Strengths and limitations of this study
=======================================

-   This study will use conventional and new measures of motoneuron excitability for the objective evaluation of spasticity.

-   This study will be the first to compare the criterion validity of the MMAS and the MTS.

-   A weakness of the study is that the tests will be carried out by one person.

Introduction {#s1}
============

Spasticity is a common symptom observed following upper motor neuron syndrome. Diseases such as stroke, traumatic brain injury, spinal cord injury, cerebral palsy and multiple sclerosis are associated with significant spasticity. Spasticity has been defined classically by Lance as a motor disorder characterised by a velocity-dependent increase in tonic stretch reflexes.[@R1] There are several studies addressing the prevalence of spasticity after stroke.[@R2] The prevalence of spasticity after a first stroke has been inconsistent, ranging between 18% and 38%.[@R3; @R4; @R5; @R6; @R7; @R8] In addition, a recent study indicated that the prevalence of spasticity in patients with stroke referred to the Department of Rehabilitation Medicine was 42.4%.[@R9] Excessive spasticity needs to be controlled, because it can interfere with functional recovery, and may lead to secondary complications such as contractures and pain.[@R10] [@R11] Reflex hyperexcitability and soft tissue stiffness have been reported to contribute to increased resistance to passive stretch.[@R12]

To assess spasticity accurately in clinical practise and for research purposes, reliable and valid tools must be used. The Ashworth and Tardieu Scales are common clinical measures of spasticity. The Ashworth Scale was originally developed in 1964, and modified by Bohannon and Smith in 1987.[@R13] [@R14] The Bohannon-Smith Modified Ashworth Scale (MAS) has been recently modified by Ansari *et al*[@R15] in 2006 as the Modified Modified Ashworth Scale (MMAS; [table 1](#BMJOPEN2012001394TB1){ref-type="table"}). The MMAS is an ordinal level measure of spasticity, which grades the intensity of spasticity from 0 to 4. The results of several studies have demonstrated that the MMAS is a reliable measure for assessing spasticity in either upper or lower limbs of patients with spasticity.[@R16; @R17; @R18; @R19; @R20; @R21; @R22]

###### 

Definitions of the Modified Tardieu Scale and the Modified Modified Ashworth Scale

  Grade   Modified Tardieu Scale (Boyd and Graham[@R27])                                                          Modified Modified Ashworth Scale (Ansari *et al*[@R15])
  ------- ------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  0       No resistance throughout the course of the passive movement                                             No increase in muscle tone
  1       Slight resistance throughout the course of the passive movement, with no clear catch at precise angle   Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension
  2       Clear catch at precise angle, interrupting the passive movement, followed by release                    Marked increase in muscle tone, manifested by a catch in the middle range and resistance throughout the remainder of the range of motion, but affected part (s) easily moved
  3       Fatigable clonus (\<10 s when maintaining pressure) occurring at precise angle                          Considerable increase in muscle tone, passive movement difficult
  4       Infatigable clonus (\>10 s when maintaining pressure) occurring at precise angle                        Affected part(s) rigid in flexion or extension

The Tardieu Scale was developed by Tardieu *et al*[@R23] in 1954. Held and Pierrot-Deseilligny[@R24] modified it in 1969, and it was further modified in 1999 by Boyd and Graham. This latest version of the Tardieu Scale is called the Modified Tardieu Scale (MTS).[@R25] [@R26] The MTS considers R2, R1 and R2−R1 to measure spasticity. The R2 is the passive range of motion measured during slow passive stretch. The R1 is the angle of muscle reaction measured during fast passive stretch, and occurs in a particular angle of 'catch' from hyperactive stretch reflex. Large and small differences between R2 and R1 indicate spasticity and muscle contracture, respectively.[@R25] [@R27] Quality of muscle reaction during fast passive stretch is also graded based on 0--4 scores and is defined as the MTS scores ([table 1](#BMJOPEN2012001394TB1){ref-type="table"}).[@R28] [@R29]

Studies regarding the reliability of the MTS have been mostly performed in children.[@R30; @R31; @R32; @R33] The reliability of the MTS has been questioned for various patient groups.[@R32] [@R34] [@R35] Paulis *et al*[@R36] compared the test−retest and inter-rater reliability of Tardieu Scale scores measured with inertial sensors (IS) and goniometry and found excellent reliability for IS. Ansari *et al*[@R34] showed insufficient inter-rater reliability for MTS when measuring elbow flexor spasticity in adult patients with hemiplegia using goniometry. In a study by Singh *et al*[@R37] it has been shown that the intrarater reliability of MTS is very good for R1, R2, R2−R1 and MTS scores across two sessions in elbow flexors and ankle plantar flexors using goniometry. A study comparing the reliability of the MTS with the Bohannon-Smith MAS in adult patients with severe brain injury found significantly higher test--retest and inter-rater reliability for MTS, however, poor-to-moderate inter-rater reliability for both scales.[@R38]

There is a paucity of literature exploring the validity of MMAS and MTS. The validity of MMAS has been evaluated neurophysiologically with the measurement of wrist flexor spasticity in patients with stroke.[@R39] Naghdi *et al*[@R39] found a significant positive correlation between the MMAS scores and H~slp~/M~slp~ ratio (r=0.39, p=0.04), traditional index of H~max~/M~max~ ratio (r=0.39, p=0.04) and H~slp~ (r=0.45, p=0.02) indicating the validity of the MMAS. In another study, the authors showed that the MMAS and the Brunnstrom recovery stages were highly correlated in the evaluation of motor recovery in patients with stroke.[@R40] Recently, the content validity of the Tardieu Scale and the Ashworth Scale was assessed in independently ambulating children with cerebral palsy.[@R41] The authors demonstrated that the Tardieu Scale was more effective than the Original Ashworth Scale in identifying the presence of spasticity, the presence of contracture and the severity of contracture. Neither scale was able to identify the severity of spasticity.[@R41]

The basic neural circuit in spasticity is the monosynaptic stretch reflex arc characterised by the sensory Ia afferent and α motor neuron.[@R42] Various neurophysiological changes have been shown to occur in muscle spasticity, including α motor neuron hyperexcitability.[@R12] [@R43] The H-reflex is a simple, non-invasive method that can be used to study reflex pathway reliably.[@R44; @R45; @R46; @R47; @R48] The H-reflex parameters of H~max~/M~max~ ratio and latency are reliable measures of α motor neuron hyperexcitability, and have been suggested for objective quantifying of muscle spasticity.[@R49] [@R50] In patients with spasticity, H-reflex latency is usually decreased and H~max~/M~max~ ratio is increased.[@R49]

The H~slp~/M~slp~ ratio (the developmental slope of the H-reflex (H~slp~) recruitment curve as a ratio of the developmental slope of the M-response (M~slp~)) has been proposed as a better indicator for evaluating the excitability of a motor neuron pool in spasticity.[@R51] [@R52] The slope of the H-reflex recruitment curve (H~slp~) representing the relationship between stimulation intensity and reflex recruitment of motor neurons is free from the H-reflex discharge collision and shows the intrinsic excitability of the motor neurons and the reflex arc.[@R52] [@R53] The H~slp~ is more sensitive than H~max~/M~max~, provides more information about the recruitment threshold and can estimate spinal excitability.[@R52] [@R54] It has been demonstrated that flexor carpi radialis (FCR) H-reflexes can be reliably evoked in poststroke paretic and non-paretic arms, and the FCR recruitment slope is a sensitive measure of  spinal excitability after stroke.[@R55] The H-reflex tests will be used for validation of the MMAS and the MTS.

Aims and objectives {#s2}
===================

No study has compared the validity of MMAS and MTS. The present neurophysiological study protocol is designed to compare the validity of the MMAS and the MTS in the assessment of poststroke wrist flexor spasticity.

Methods {#s3}
=======

Study design {#s3a}
------------

This cross-sectional, non-interventional study is designed for comparing the criterion validity between the MMAS and the MTS in the assessment of wrist flexor spasticity in patients poststroke. The clinical measures of MMAS and MTS will be obtained, and will be correlated with neurophysiological measures of H-reflex latency; H~max~/M~max~ ratio; H~slp~ and H~slp~/M~slp~ ratio.

Setting {#s3b}
-------

The measurements will be taken at the Department of Electrophysiology, University Hospital of Shafa in Tehran, Iran.

Approval of study protocol {#s3c}
--------------------------

The study protocol has been approved by the Research Council, School of Rehabilitation, Tehran University of Medical Sciences (TUMS) and Ethical approval has been granted by TUMS Ethics Committee (Reference number 1322).

Informed consent {#s3d}
----------------

Written informed consent from the eligible subjects will be obtained before tests are performed. We will instruct patients that they may obtain any information about the detail of the study from the investigator, and they may discontinue their participation in the study at any time.

Participants {#s3e}
------------

Patients with stroke who attend the Rehabilitation clinics of TUMS will be screened for eligibility. Eligible patients will be invited to participate in the study. The study is designed to include 32 subjects with the following criteria. Inclusion criteria will be (1) first stroke, (2) history of stroke between 1 and 24 months, (3) age between 40 and 65 years and (4) ability to understand and follow instructions. Exclusion criteria will be (1) fixed contracture at wrist and elbow joints, (2) wrist pain due to degenerative changes, (3) taking antispastic drugs, (4) contraindication of  passive movement at wrist joint, (5) cervical discopathy, (6) diabetes and (7) non-consent.

Procedures {#s3f}
----------

The patients will be interviewed to collect demographic characteristics including age; aetiology (ie, ischaemic or vascular stroke), time elapsed from the onset of stroke and affected side. Effort will be made to provide a similar testing condition. All measurements will be taken in the morning hours between 9:00 and 12:00. Before testing commencement, all patients will be asked to rest on the bed with shoes removed for 5 min and remain comfortable and relaxed. To provide a quiet testing environment, all tests will be performed in a closed quiet room with natural light from windows. The temperature of the testing room will be set at approximately 25°C. We will also ask the patients to empty their bladder prior to testing. The room is electrically shielded and earth-grounded for H-reflex measurements.

The wrist flexors will be tested in this study, because they are usually spastic in patients poststroke, and spasticity can be reliably measured in wrist flexors.[@R17] [@R18] [@R56] Clinical and neurophysiological tests will be performed in a single session. Wrist flexor spasticity will be assessed clinically on the affected side using MMAS and MTS. For MTS, the components of R1, R2, R2−R1 and quality of muscle reaction will be measured. The sequence of tests will be randomised by tossing a coin. The tester will be tossing the coin to randomise the procedure and will be observed by an impartial colleague. The neurophysiological data will also be collected from the affected side. One trained physiotherapist will perform both clinical and neurophysiological tests. The clinical tests will be applied first. The tester will be blinded to the neurophysiological data analyses. The analyst of neurophysiological data will be blinded to the clinical testing results.

Outcome measures {#s3g}
----------------

Muscle spasticity is primarily due to an exaggerated stretch reflex and α motor neuron excitability.[@R1] The MMAS and MTS will be used for the assessment of muscle spasticity. The H-reflex is an objective method for the measurement of spasticity.[@R49] The H-reflex parameters of latency; H~max~/M~max~ ratio; H~slp~; and H~slp~/M~slp~ ratio will be applied to examine α motor neuron excitability.

The H~max~/M~max~ ratio indicates the level of motoneuron excitability. The H~slp~ is a measure of the relationship between the number of motoneurons activated and a given incremental rise in stimulation intensity.[@R51] [@R52] The H~slp~/M~slp~ ratio is a new method of spasticity measurement, and presumes that the developmental slope of the H-reflex (H~slp~) recruitment curve as a ratio of the developmental slope of the M-response (M~slp~) is a better parameter for evaluating the motoneuron excitability.

The Modified Modified Ashworth Scale {#s3h}
------------------------------------

Wrist flexor spasticity will be quantified using the clinical scale MMAS, which has been shown to be reliable at the wrist joint.[@R17] [@R18] The procedure used and described in previous studies will be followed to measure wrist flexor spasticity. Briefly, the patient will be in supine position, head in midline, and arms alongside the trunk with shoulder in slight abduction. The rater will hold the forearm in mid-position just proximal to the wrist joint with one hand, and will grasp the patients hand with the other hand. The rater will move the wrist from maximum possible flexion to maximal possible extension counting 1001.[@R17] [@R18] The rater will score muscle spasticity from 0 to 4. Only one passive stretch will be applied to rate spasticity.[@R15]

The Modified Tardieu Scale {#s3i}
--------------------------

A standard goniometer will be utilised to measure R2 and R1. The patient will be in sitting position with elbow joint flexed at 90°. The stretching velocity of V1 and V3 will be applied to measure R2 and R1, respectively. The quality of muscle reaction will be graded at the stretching velocity of V3 as well.[@R16] [@R17] The difference between R2 and R1 will be the measure of the dynamic component of spasticity.

Measurement of H-reflex {#s3j}
-----------------------

As with the clinical test, the patient will be positioned in supine, head in midline and arms alongside the trunk. The patients will be asked to remain calm, and relax completely during testing.

The H-reflex and the M-wave will be obtained using an EMG machine (Myto П, Italy). The H-reflex will be elicited in the FCR muscle of the affected side of the participants with the arm in supination. The H-reflex in FCR muscle has been commonly employed in studies of H-reflex in the upper limb, and can be reliably evoked and measured.[@R46] [@R49] [@R57] [@R58] A digital thermometer will be used to measure the skin temperature. The bandpass filter will be set at 5 Hz--3 kHz, sweep speed at 5 ms/div and sensitivity at 200--500 µV.

The stimulator will apply rectangular electric pulses with 1 ms duration, every 5 s.[@R39] [@R40] Paired surface electrodes (Ag/AgCl) will be attached to the skin on the muscle belly. The median nerve will be stimulated at the elbow crease using a bipolar stimulating electrode. The stimulating electrodes will be positioned in line with the median nerve in the cubital fossa just medial to the biceps brachii tendon with the cathode proximal to the anode to prevent anodal block.[@R59]

The recording electrodes will be placed over the muscle belly of the FCR. The active electrode will be placed on the belly of the FCR at one-third of the proximal distance between the medial epicondyle of the humerous and the radial styloid. The reference electrode will be positioned 4 cm distal and lateral to the active one. The electric resistance between the two electrodes will be less than 10 kΩ. The ground electrode will be attached to the skin between stimulating and recording electrodes. Stepwise increase in stimulus intensity will be used to record the H-reflex and M-wave. The stimulus intensity will start at 0.5 mA and will be increased in steps of 0.5 mA to record H~max~ and M~max~.[@R39] [@R40] H-reflex conditioning will not be used in this protocol, as FCR H-reflex can be easily evoked without facilitation in most cases.[@R47]

Recruitment curves {#s3k}
------------------

To build the recruitment curves of H-reflex and M-waves, we will follow the methods described elsewhere.[@R39] [@R40] [@R51] [@R52] [@R60] Five pulses will be delivered sequentially at each stimulus intensity and the mean amplitude of evoked H-reflexes and the M-responses will be calculated. The amplitudes will be measured peak to peak. Mean amplitudes will be normalised according to the following formula:

Stimulus intensities will be presented as the ratio of the threshold intensity of the M-wave (M~th~). All data measured at stimulus intensities less than the threshold of the M-wave will be used to determine the H~slp~. Data from M~th~ up to maximum amplitude of M-wave will determine the M~slp~. Equation of simple linear regression will be determined, and the slope of this line will be considered as H~slp~ or M~slp~. Maximum mean amplitude of the H-reflex and maximum mean amplitude of the M-wave will be regarded as H~max~ and M~max~, respectively. The H~max~ relative to M~max~ is H~max~/M~max~ ratio. The H-reflex latency will be calculated from stimulus wave to the onset of first deflection of the H-wave, and the amplitude of recorded reflexes and waves will be measured.

Sample size calculation {#s3l}
-----------------------

In the study by Naghdi *et* al,^39^ correlation of the MMAS with the H~max~/M~max~ ratio or the H~slp~/M~slp~ ratio was r=0.39. Assuming the correlation to be 0.4, and to show a similar validity with 0.95% power at 5% significance level, it will require that data are taken on 32 participants.

Statistical analysis {#s3m}
--------------------

To determine the validity of the clinical tests, the relationships between the clinical tests and the H-reflex indices will be assessed by calculating Spearman\'s ρ test (ie, MMAS and the ordinal component of the MTS) or Pearson correlation test (ie, ratio components of the MTS). Comparing correlations test will be used to compare the validity of the MMAS and the MTS.[@R61]

Results {#s4}
=======

Demographic characteristics {#s4a}
---------------------------

Demographic characteristics of participants will be illustrated as shown in [table 2](#BMJOPEN2012001394TB2){ref-type="table"}.

###### 

Demographic and clinical characteristics

                        Number   Mean (SD)   Minimum   Maximum
  --------------------- -------- ----------- --------- ---------
  Gender (M/F)                                         
  Age                                                  
  Weight                                               
  Height                                               
  BMI                                                  
  Time since stroke                                    
  Affected side (R/L)                                  

BMI, body mass index; R/L, right or left.

Clinical characteristics {#s4b}
------------------------

Clinical spasticity grades with MMAS, MTS measures and quality of muscle reaction will be illustrated in [table 3](#BMJOPEN2012001394TB3){ref-type="table"}.

###### 

The results for spasticity grades and measurements of R1, R2 and R2−R1

  MTS measures   Median (IQR)   Mean (SD)   Minimum--Maximum   95% CI
  -------------- -------------- ----------- ------------------ --------
  R1                                                           
  R2                                                           
  R2−R1                                                        
  MMAS grades                                                  
  MTS grades                                                   

MMAS, Modified Modified Ashworth Scale; MTS, Modified Tardieu Scale; R1, angle of muscle reaction; R2, passive range of motion; R2−R1, dynamic component of spasticity.

Neurophysiological data {#s4c}
-----------------------

Objective neurophysiological assessment results using the H-reflex are shown in [table 4](#BMJOPEN2012001394TB4){ref-type="table"}.

###### 

The results for H-reflex indices

                  Mean (SD)   Minimum--Maximum   95% CI
  --------------- ----------- ------------------ --------
  H~max~/M~max~                                  
  Latency                                        
  H~slp~/M~slp~                                  
  H~slp~                                         

Criterion validity {#s4d}
------------------

The criterion validity will be analysed by correlations between the clinical measures and neurophysiological tests. Criterion validity will be established when significant moderate correlations between the MMAS/the MTS and the neurophysiological measures are found.  The results of correlation analyses will be presented in [table 5](#BMJOPEN2012001394TB5){ref-type="table"}.

###### 

Correlation coefficients between spasticity clinical measures and neurophysiological tests

           H~max~/M~max~              Latency   H~slp~/M~slp~   H~slp~   
  -------- -------------------------- --------- --------------- -------- --
  MMAS     Spearman\'s ρ sig.                                            
  MTS      Spearman\'s ρ sig.                                            
  R2--R1   Pearson correlation sig.                                      

MMAS, Modified Modified Ashworth Scale; MTS, Modified Tardieu Scale; sig., significance.

Discussion {#s5}
==========

This article describes a neurophysiological study protocol for comparative evaluation of the validity of two important clinical measures in the field of neurological rehabilitation. To our knowledge, this investigation will be the first to compare the criterion validity of the MMAS and the MTS. This protocol utilises conventional and new indicators of motoneuron excitability in spasticity for comparative validity evaluation. Further, the protocol utilises standard methodology for spasticity assessment to indicate the excitability of the α motoneuron pool.[@R49]

The results of the present protocol will be important. Owing to the limitations of the Ashworth Scale and questioned reliability and validity,[@R62] the new MMAS has emerged to improve the metric characteristics of the scales. The results of the metrics for the MMAS have been encouraging up to this point. The MMAS needs to be further examined for additional psychometric properties and be utilised during intervention-based studies.[@R63] Since the original and MAS have been reported to have poor reliability and validity the MTS has been suggested as an alternative and suitable measure for use in assessment of spasticity.[@R29] [@R64] However, the results of reliability for the MTS have been mixed, with a dearth of studies exploring the validity of the MTS. This study will be the first report investigating the validity of the MTS through establishing correlation between the MTS and the α motor neuron excitability indicators. While the MTS has been explained theoretically as a suitable spasticity measure, there is no evidence to compare this scale with existing clinical measures such as the MMAS. The results of this protocol will provide neurophysiological evidence for the validity of the MMAS and the MTS as clinical scales for the measurement of muscle spasticity.

Limitations {#s6}
===========

A limitation of the study is that the tests will be performed by only one person, which is the most significant limitation of the study.
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